Login to BlackFacts.com using your favorite Social Media Login. Click the appropriate button below and you will be redirected to your Social Media Website for confirmation and then back to Blackfacts.com once successful.
Enter the email address and password you used to join BlackFacts.com. If you cannot remember your login information, click the “Forgot Password” link to reset your password.
After 30 years of dominating South African politics, the ruling African National Congress will face its toughest election Wednesday as most opinion polls predict it will lose its parliamentary majority for the first time
In May, Burundi held a presidential election which was won by Evariste Ndayishimiye, candidate of the ruling National Council for the Defense of Democracy - Forces for the Defense of Democracy (CNDD-FDD) party.
Ndayishimiye was hurriedly sworn in after the untimely death of president Pierre Nkurunziza in June.
Rights violations continue
The Council encouraged donor countries which had suspended aid to Burundi to continue dialogue towards resumption of development assistance.
A report by a UN watchdog in September said human rights violations were still being committed in Burundi, including sexual violence and murder.
The country was plunged into a crisis in April 2015 when Ndayishimiye’s predecessor Pierre Nkurunziza decided to run for a controversial third term, which he ultimately won in July 2015.
His candidature, which was opposed by the opposition and civil society groups, resulted in a wave of protests, violence and even a failed coup in May 2015.
Hundreds of people were killed and over 300,000 fled to neighboring countries.
Morocco is gearing up for an ambitious COVID-19 vaccination program, aiming to vaccinate 80% of its adults in an operation starting this month that’s relying initially on a China's Sinopharm vaccine.
The first injections could come within days, a Health Ministry official told The Associated Press.
While Britain began its vaccination program Tuesday with the Pfizer-BioNTech vaccine and the U.S. and European Union are racing to approve a series of Western-made vaccines, other governments are looking to use vaccines from China and Russia.
Morocco is battling a resurgence in virus infections, with the number of recorded deaths from the virus surpassing 6,000. The North African kingdom is pinning its hopes on two vaccine candidates, one developed by China’s Sinopharm and the other by Britain’s Oxford University and AstraZeneca.
The Sinopharm vaccine has been approved for emergency use in a few countries and the company is still conducting late-stage clinical trials in 10 countries.
Morocco’s government seeks to vaccinate 80% of its adults, or 25 million people, as soon as the vaccines are approved by domestic regulators. Priority will go to medical staff and other front-line workers, as well as the elderly.
It will start with the Sinopharm vaccine, which was tested on 600 Moroccans as part of clinical trials this autumn. Morocco has ordered 10 million doses of the vaccine.
The initial deliveries will come from China, but Morocco also plans to produce the vaccine locally, Abdelhakim Yahyan, a senior official at the Ministry of Health, told the state-owned news agency MAP.
In the Moroccan trial of the Sinopharm vaccine, carried out in Casablanca and the capital Rabat from August through November, healthy volunteers received two separate doses of the vaccine. In the advanced trial, volunteers either received the vaccine or a placebo.
According to the health minister, early results have proven the vaccine to be “safe and effective” with no severe side effects reported.
Sinopharm’s shot relies on a tested technology, using a killed virus to deliver the vaccine, similar to how polio immunizations are made.
Leading Western competitors, like the vaccine made by Oxford and AstraZeneca, use newer, less-proven technology to target the coronavirus’ spike protein.
AP
Today’s DAILY LOTTO jackpot is estimated at R450,000! The Daily Lotto is a lottery game that guarantees a jackpot for every draw.
Living with HIV as a Refugee
For most of the Ethiopian refugees who fled the conflict in Tigray to Eastern Sudan, life at the camps has been hard. But there are even more challenges for those living with chronic illnesses without access to medication. Aksamaweet Garazgerer, an HIV+ Ethiopian refugee, explains the stark difference in how she feels depending on the availability of her prescription drugs, \"When I take the medication with the food, I am good. I don't get sick. I don't have a fever. I don't have a cold. But now my supply has finished. I am so tired. I keep fainting.\"
Many living with HIV are going without antiretroviral medication. A situation compounded by the inadequate shelter and difficult daily survival conditions — fearing for their lives for different reasons.
Terhas Adiso, another Ethiopian refugee living with HIV, is worried about her health as time goes by, \"This week if I don't find this medication, I will suffer. Now when you see the dead they don't get up. I'll be as good as dead. I am scared for myself and my son, he is young. He will be left alone. For my son, I am crying and I am scared.\"
Exhausted, stressed and having to stay strong for their families in light of the already dire situation at the camp is a lot for anyone to carry, but all hope is not lost for these Ethiopian war survivors.
Despite uncertainties over Joe Biden’s approach to trade with China, major U.S. companies are optimistic about the business outlook under the new administration.
